Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

H.C. Wainwright 22nd Annual Global Investment Conference – Virtual Conference

14 Sep 2020 - 16 Sep 2020
  • Events & presentations

Bernard Gilly, Chief Executive Officer and Thomas Gidoin, Chief Financial Officer will participate to the H.C. Wainwright 22nd Annual Global Investment Conference and will host investor meetings.

Bernard Gilly, Chief Executive Officer, will present on Wednesday, September 16th, 2020 at 1:00 p.m. ET (7.00pm CET).

Back to list
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page